title: Withdrawal of repeated morphine enhances histamine-induced scratching responses in mice.
abstract: An itch is experientially well known that the scratching response of conditions such as atopic dermatitis is enhanced under psychological stress. Morphine is typical narcotic drug that induces a scratching response upon local application as an adverse drug reaction. Although long-term treatment with morphine will cause tolerance and dependence, morphine withdrawal can cause psychologically and physiologically stressful changes in humans. In this study, we evaluated the effects of morphine withdrawal on histamine-induced scratching behavior in mice. Administration of morphine with progressively increasing doses (10-50 mg/kg, i.p.) was performed for 5 consecutive days. At 3, 24, 48, and 72 hr after spontaneous withdrawal from the final morphine dose, histamine was intradermally injected into the rostral part of the back and then the number of bouts of scratching in 60 min was recorded and summed. We found that at 24 hr after morphine withdrawal there was a significant increase in histamine-induced scratching behavior. The spinal c-Fos positive cells were also significantly increased. The relative adrenal weight increased and the relative thymus weight decreased, both significantly. Moreover, the plasma corticosterone levels changed in parallel with the number of scratching bouts. These results suggest that morphine withdrawal induces a stressed state and enhances in histamine-induced scratching behavior. Increased reaction against histamine in the cervical vertebrae will participate in this stress-induced itch enhancement.
authors.affiliation: Departments of Pharmacology, School of Pharmaceutical Sciences, Ohu University , Tomitamachi, Koriyama, Fukushima , Japan and.
authors.forename: Kenji
authors.initials: K
authors.lastname: Abe
authors.forename: Kanayo
authors.initials: K
authors.lastname: Kobayashi
authors.forename: Saori
authors.initials: S
authors.lastname: Yoshino
authors.forename: Kyoji
authors.initials: K
authors.lastname: Taguchi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nojima
mesh_terms: D000701:Analgesics, Opioid / Q000008:administration & dosage; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D003345:Corticosterone / Q000097:blood; D004305:Dose-Response Relationship, Drug; D006632:Histamine / Q000008:administration & dosage / Q000378:metabolism*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009020:Morphine / Q000008:administration & dosage*; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D011537:Pruritus / Q000209:etiology*; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology*; D013997:Time Factors
chemical_list: D000701:Analgesics, Opioid; D016760:Proto-Oncogene Proteins c-fos; D009020:Morphine; D006632:Histamine; D003345:Corticosterone
keywords: Adverse drug effect; c-Fos; corticosterone; itch; stress; withdrawal syndrome